Background. Racial/ethnic groups' participation in clinical trials is a relatively new area of research that warrants attention. Although racial/ethnic groups have been Included in experimental studies since the 1940% they were not included in significant numbers in clinical trials for cancer. Clini
Viewpoints and concerns of a clinical trial participant
β Scribed by Rosaline R. Joseph
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 185 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This paper reviews what is known about attitudes toward clinical trials among patients and the public, the use of surrogates (physicians and patients) to determine whether a clinical trial is acceptable, and other empiric data available on this issue. Other concerns related to the conduct of clinica
## Background: The selection of clinical trials participants is a critical step in study design, because it affects the generalizability of recommendations made on the basis of trial results and public acceptance of medical research. the authors assessed the heterogeneity of subgroups in cancer tre
## Abstract ## BACKGROUND The generalizability of clinical trial results is questionable, because fewer than 5% of cancer patients participate. The authors examined the comparability of clinical trial participants and nonparticipants and the potential impact of differences. ## METHODS A retrospe